Clinical trial
Dose Escalating Study for Amphinex-based PCI of Bleomycin.
NCT01872923
Study timeline
Study start (unknown)2012-01-01Date precision: month
Registry last updated2014-06-16
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Cutaneous or Sub-cutaneous Malignanciesunresolved
Interventions
Sponsors & collaborators
PCI Biotech ASlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01872923 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.